Global Anthrax Vaccines Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Anthrax Vaccines Market
The global Anthrax Vaccines market size is projected to reach US$ 1016.5 million by 2027, from US$ 612 million in 2020, at a CAGR of 7.6% during 2021-2027.
Global Anthrax Vaccines Scope and Segment
The global Anthrax Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anthrax Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Live Vaccines
Cell free PA Vaccines
By the end users/application, this report covers the following segments
Human Use
Animal Use
Competitive Landscape:
The report provides a list of all the key players in the Anthrax Vaccines market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Anthrax Vaccines key manufacturers in this market include:
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC

TABLE OF CONTENT

1 Anthrax Vaccines Market Overview
1.1 Anthrax Vaccines Product Overview
1.2 Anthrax Vaccines Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Cell free PA Vaccines
1.3 Global Anthrax Vaccines Market Size by Type
1.3.1 Global Anthrax Vaccines Market Size Overview by Type (2016-2027)
1.3.2 Global Anthrax Vaccines Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Anthrax Vaccines Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Anthrax Vaccines Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Anthrax Vaccines Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Anthrax Vaccines Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Anthrax Vaccines Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Anthrax Vaccines Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Anthrax Vaccines Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anthrax Vaccines Sales Breakdown by Type (2016-2030)
1.4.2 Europe Anthrax Vaccines Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Anthrax Vaccines Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Anthrax Vaccines Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Anthrax Vaccines Sales Breakdown by Type (2016-2030)

2 Global Anthrax Vaccines Market Competition by Company
2.1 Global Top Players by Anthrax Vaccines Sales (2016-2030)
2.2 Global Top Players by Anthrax Vaccines Revenue (2016-2030)
2.3 Global Top Players Anthrax Vaccines Price (2016-2030)
2.4 Global Top Manufacturers Anthrax Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anthrax Vaccines Market Competitive Situation and Trends
2.5.1 Anthrax Vaccines Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Anthrax Vaccines Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2020)
2.7 Date of Key Manufacturers Enter into Anthrax Vaccines Market
2.8 Key Manufacturers Anthrax Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Anthrax Vaccines Status and Outlook by Region
3.1 Global Anthrax Vaccines Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Anthrax Vaccines Historic Market Size by Region
3.2.1 Global Anthrax Vaccines Sales in Volume by Region (2016-2030)
3.2.2 Global Anthrax Vaccines Sales in Value by Region (2016-2030)
3.2.3 Global Anthrax Vaccines Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Anthrax Vaccines Forecasted Market Size by Region
3.3.1 Global Anthrax Vaccines Sales in Volume by Region (2022-2027)
3.3.2 Global Anthrax Vaccines Sales in Value by Region (2022-2027)
3.3.3 Global Anthrax Vaccines Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Anthrax Vaccines by Application
4.1 Anthrax Vaccines Market Segment by Application
4.1.1 Human Use
4.1.2 Animal Use
4.2 Global Anthrax Vaccines Market Size by Application
4.2.1 Global Anthrax Vaccines Market Size Overview by Application (2016-2027)
4.2.2 Global Anthrax Vaccines Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Anthrax Vaccines Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Anthrax Vaccines Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Anthrax Vaccines Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Anthrax Vaccines Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Anthrax Vaccines Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Anthrax Vaccines Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Anthrax Vaccines Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anthrax Vaccines Sales Breakdown by Application (2016-2030)
4.3.2 Europe Anthrax Vaccines Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Anthrax Vaccines Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Anthrax Vaccines Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Anthrax Vaccines Sales Breakdown by Application (2016-2030)

5 North America Anthrax Vaccines by Country
5.1 North America Anthrax Vaccines Historic Market Size by Country
5.1.1 North America Anthrax Vaccines Sales in Volume by Country (2016-2030)
5.1.2 North America Anthrax Vaccines Sales in Value by Country (2016-2030)
5.2 North America Anthrax Vaccines Forecasted Market Size by Country
5.2.1 North America Anthrax Vaccines Sales in Volume by Country (2022-2027)
5.2.2 North America Anthrax Vaccines Sales in Value by Country (2022-2027)

6 Europe Anthrax Vaccines by Country
6.1 Europe Anthrax Vaccines Historic Market Size by Country
6.1.1 Europe Anthrax Vaccines Sales in Volume by Country (2016-2030)
6.1.2 Europe Anthrax Vaccines Sales in Value by Country (2016-2030)
6.2 Europe Anthrax Vaccines Forecasted Market Size by Country
6.2.1 Europe Anthrax Vaccines Sales in Volume by Country (2022-2027)
6.2.2 Europe Anthrax Vaccines Sales in Value by Country (2022-2027)

7 Asia-Pacific Anthrax Vaccines by Region
7.1 Asia-Pacific Anthrax Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Anthrax Vaccines Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Anthrax Vaccines Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Anthrax Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Anthrax Vaccines Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Anthrax Vaccines Sales in Value by Region (2022-2027)

8 Latin America Anthrax Vaccines by Country
8.1 Latin America Anthrax Vaccines Historic Market Size by Country
8.1.1 Latin America Anthrax Vaccines Sales in Volume by Country (2016-2030)
8.1.2 Latin America Anthrax Vaccines Sales in Value by Country (2016-2030)
8.2 Latin America Anthrax Vaccines Forecasted Market Size by Country
8.2.1 Latin America Anthrax Vaccines Sales in Volume by Country (2022-2027)
8.2.2 Latin America Anthrax Vaccines Sales in Value by Country (2022-2027)

9 Middle East and Africa Anthrax Vaccines by Country
9.1 Middle East and Africa Anthrax Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Anthrax Vaccines Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Anthrax Vaccines Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Anthrax Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Anthrax Vaccines Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Anthrax Vaccines Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Anthrax Vaccines Business
10.1 Emergent BioSolutions
10.1.1 Emergent BioSolutions Corporation Information
10.1.2 Emergent BioSolutions Introduction and Business Overview
10.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.1.4 Emergent BioSolutions Anthrax Vaccines Products Offered
10.1.5 Emergent BioSolutions Recent Development
10.2 Merial
10.2.1 Merial Corporation Information
10.2.2 Merial Introduction and Business Overview
10.2.3 Merial Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.2.4 Merial Anthrax Vaccines Products Offered
10.2.5 Merial Recent Development
10.3 Merck
10.3.1 Merck Corporation Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.3.4 Merck Anthrax Vaccines Products Offered
10.3.5 Merck Recent Development
10.4 Zoetis
10.4.1 Zoetis Corporation Information
10.4.2 Zoetis Introduction and Business Overview
10.4.3 Zoetis Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.4.4 Zoetis Anthrax Vaccines Products Offered
10.4.5 Zoetis Recent Development
10.5 Bayer Sanidad Animal
10.5.1 Bayer Sanidad Animal Corporation Information
10.5.2 Bayer Sanidad Animal Introduction and Business Overview
10.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.5.4 Bayer Sanidad Animal Anthrax Vaccines Products Offered
10.5.5 Bayer Sanidad Animal Recent Development
10.6 Colorado Serum
10.6.1 Colorado Serum Corporation Information
10.6.2 Colorado Serum Introduction and Business Overview
10.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.6.4 Colorado Serum Anthrax Vaccines Products Offered
10.6.5 Colorado Serum Recent Development
10.7 PharmAthene
10.7.1 PharmAthene Corporation Information
10.7.2 PharmAthene Introduction and Business Overview
10.7.3 PharmAthene Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.7.4 PharmAthene Anthrax Vaccines Products Offered
10.7.5 PharmAthene Recent Development
10.8 Tiankang
10.8.1 Tiankang Corporation Information
10.8.2 Tiankang Introduction and Business Overview
10.8.3 Tiankang Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.8.4 Tiankang Anthrax Vaccines Products Offered
10.8.5 Tiankang Recent Development
10.9 Biogénesis-Bago
10.9.1 Biogénesis-Bago Corporation Information
10.9.2 Biogénesis-Bago Introduction and Business Overview
10.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.9.4 Biogénesis-Bago Anthrax Vaccines Products Offered
10.9.5 Biogénesis-Bago Recent Development
10.10 CAVAC
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Anthrax Vaccines Product Category, Application and Specification
10.10.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2016-2030)
10.10.4 Main Business Overview
10.10.5 CAVAC Recent Development
10.11 Rosenbusch
10.11.1 Rosenbusch Corporation Information
10.11.2 Rosenbusch Introduction and Business Overview
10.11.3 Rosenbusch Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.11.4 Rosenbusch Anthrax Vaccines Products Offered
10.11.5 Rosenbusch Recent Development
10.12 Agrovet
10.12.1 Agrovet Corporation Information
10.12.2 Agrovet Introduction and Business Overview
10.12.3 Agrovet Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.12.4 Agrovet Anthrax Vaccines Products Offered
10.12.5 Agrovet Recent Development
10.13 Vecol
10.13.1 Vecol Corporation Information
10.13.2 Vecol Introduction and Business Overview
10.13.3 Vecol Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.13.4 Vecol Anthrax Vaccines Products Offered
10.13.5 Vecol Recent Development
10.14 CVCRI
10.14.1 CVCRI Corporation Information
10.14.2 CVCRI Introduction and Business Overview
10.14.3 CVCRI Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.14.4 CVCRI Anthrax Vaccines Products Offered
10.14.5 CVCRI Recent Development
10.15 IVPM
10.15.1 IVPM Corporation Information
10.15.2 IVPM Introduction and Business Overview
10.15.3 IVPM Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.15.4 IVPM Anthrax Vaccines Products Offered
10.15.5 IVPM Recent Development
10.16 Prondil
10.16.1 Prondil Corporation Information
10.16.2 Prondil Introduction and Business Overview
10.16.3 Prondil Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.16.4 Prondil Anthrax Vaccines Products Offered
10.16.5 Prondil Recent Development
10.17 CDV
10.17.1 CDV Corporation Information
10.17.2 CDV Introduction and Business Overview
10.17.3 CDV Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.17.4 CDV Anthrax Vaccines Products Offered
10.17.5 CDV Recent Development
10.18 Indian Immunologicals
10.18.1 Indian Immunologicals Corporation Information
10.18.2 Indian Immunologicals Introduction and Business Overview
10.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.18.4 Indian Immunologicals Anthrax Vaccines Products Offered
10.18.5 Indian Immunologicals Recent Development
10.19 Botswana Vaccine Institute
10.19.1 Botswana Vaccine Institute Corporation Information
10.19.2 Botswana Vaccine Institute Introduction and Business Overview
10.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.19.4 Botswana Vaccine Institute Anthrax Vaccines Products Offered
10.19.5 Botswana Vaccine Institute Recent Development
10.20 Ceva Santé Animale
10.20.1 Ceva Santé Animale Corporation Information
10.20.2 Ceva Santé Animale Introduction and Business Overview
10.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.20.4 Ceva Santé Animale Anthrax Vaccines Products Offered
10.20.5 Ceva Santé Animale Recent Development
10.21 Intervac
10.21.1 Intervac Corporation Information
10.21.2 Intervac Introduction and Business Overview
10.21.3 Intervac Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.21.4 Intervac Anthrax Vaccines Products Offered
10.21.5 Intervac Recent Development
10.22 JOVAC
10.22.1 JOVAC Corporation Information
10.22.2 JOVAC Introduction and Business Overview
10.22.3 JOVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2016-2030)
10.22.4 JOVAC Anthrax Vaccines Products Offered
10.22.5 JOVAC Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anthrax Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anthrax Vaccines Industrial Chain Analysis
11.4 Anthrax Vaccines Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anthrax Vaccines Distributors
12.3 Anthrax Vaccines Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample